Tarek Shalaby

3.9k total citations
33 papers, 1.2k citations indexed

About

Tarek Shalaby is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Tarek Shalaby has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 11 papers in Cancer Research and 9 papers in Genetics. Recurrent topics in Tarek Shalaby's work include Glioma Diagnosis and Treatment (9 papers), Neuroblastoma Research and Treatments (7 papers) and MicroRNA in disease regulation (7 papers). Tarek Shalaby is often cited by papers focused on Glioma Diagnosis and Treatment (9 papers), Neuroblastoma Research and Treatments (7 papers) and MicroRNA in disease regulation (7 papers). Tarek Shalaby collaborates with scholars based in Switzerland, United States and Germany. Tarek Shalaby's co-authors include Michael A. Grotzer, Giulio Fiaschetti, Alexandre Arcaro, Thomas Seebeck, André O. von Bueren, Martin Baumgartner, Alexandre Arcaro, Doris Lang, Ana Guerreiro Stücklin and Olivier Delattre and has published in prestigious journals such as PLoS ONE, Biochemical Journal and Clinical Cancer Research.

In The Last Decade

Tarek Shalaby

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tarek Shalaby Switzerland 22 832 277 218 178 175 33 1.2k
Toshihiko Kuroda Japan 18 711 0.9× 149 0.5× 187 0.9× 609 3.4× 213 1.2× 40 1.5k
Anna Onnis Italy 22 525 0.6× 257 0.9× 91 0.4× 385 2.2× 222 1.3× 38 1.1k
Andrea Muscat Australia 11 473 0.6× 116 0.4× 299 1.4× 384 2.2× 232 1.3× 15 970
Wim Vos Netherlands 19 483 0.6× 205 0.7× 100 0.5× 560 3.1× 413 2.4× 24 1.2k
Anna Coenen-Stass United Kingdom 17 741 0.9× 272 1.0× 78 0.4× 136 0.8× 238 1.4× 28 1.1k
Sarah J. Hill United States 11 805 1.0× 111 0.4× 63 0.3× 391 2.2× 136 0.8× 36 1.2k
Adam Studebaker United States 13 396 0.5× 140 0.5× 149 0.7× 444 2.5× 146 0.8× 21 885
Rainer Will Germany 19 763 0.9× 311 1.1× 48 0.2× 202 1.1× 140 0.8× 50 1.3k
Abeba Tesfaye United States 16 710 0.9× 144 0.5× 39 0.2× 199 1.1× 139 0.8× 19 1.1k
Anna Kalota United States 17 901 1.1× 219 0.8× 205 0.9× 339 1.9× 164 0.9× 39 1.5k

Countries citing papers authored by Tarek Shalaby

Since Specialization
Citations

This map shows the geographic impact of Tarek Shalaby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarek Shalaby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarek Shalaby more than expected).

Fields of papers citing papers by Tarek Shalaby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tarek Shalaby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarek Shalaby. The network helps show where Tarek Shalaby may publish in the future.

Co-authorship network of co-authors of Tarek Shalaby

This figure shows the co-authorship network connecting the top 25 collaborators of Tarek Shalaby. A scholar is included among the top collaborators of Tarek Shalaby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tarek Shalaby. Tarek Shalaby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Friedrich, Carsten, Tarek Shalaby, Christoph Oehler, et al.. (2017). Tropomyosin receptor kinase C (TrkC) expression in medulloblastoma: relation to the molecular subgroups and impact on treatment response. Child s Nervous System. 33(9). 1463–1471. 4 indexed citations
2.
Shalaby, Tarek & Michael A. Grotzer. (2015). MYC as Therapeutic Target for Embryonal Tumors: Potential and Challenges. Current Cancer Drug Targets. 16(1). 2–21. 14 indexed citations
3.
Shalaby, Tarek & Michael A. Grotzer. (2015). Tumor-Associated CSF MicroRNAs for the Prediction and Evaluation of CNS Malignancies. International Journal of Molecular Sciences. 16(12). 29103–29119. 34 indexed citations
4.
Shalaby, Tarek, et al.. (2015). Detection and quantification of extracellular microRNAs in medulloblastoma. Journal of Cancer Metastasis and Treatment. 1(2). 67–67. 14 indexed citations
5.
Grählert, Jasmin, et al.. (2015). The Ser/Thr kinase MAP4K4 drives c-Met-induced motility and invasiveness in a cell-based model of SHH medulloblastoma. SpringerPlus. 4(1). 19–19. 29 indexed citations
6.
Fiaschetti, Giulio, Christina I. Schroeder, Deborah Castelletti, et al.. (2014). NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma. Acta Neuropathologica Communications. 2(1). 39–39. 30 indexed citations
7.
Shalaby, Tarek, Giulio Fiaschetti, Martin Baumgartner, & Michael A. Grotzer. (2014). MicroRNA Signatures as Biomarkers and Therapeutic Target for CNS Embryonal Tumors: The Pros and the Cons. International Journal of Molecular Sciences. 15(11). 21554–21586. 30 indexed citations
8.
Shalaby, Tarek, Giulio Fiaschetti, Kazuo Nagasawa, et al.. (2013). G-Quadruplexes as Potential Therapeutic Targets for Embryonal Tumors. Molecules. 18(10). 12500–12537. 37 indexed citations
9.
Christiansen, Ditte G., Tiziana P. Cremona, Tarek Shalaby, et al.. (2012). Novel Agents Targeting the IGF-1R/PI3K Pathway Impair Cell Proliferation and Survival in Subsets of Medulloblastoma and Neuroblastoma. PLoS ONE. 7(10). e47109–e47109. 23 indexed citations
10.
Stücklin, Ana Guerreiro, Sarah Fattet, Alexandra N. Elsing, et al.. (2011). A Sensitized RNA Interference Screen Identifies a Novel Role for the PI3K p110γ Isoform in Medulloblastoma Cell Proliferation and Chemoresistance. Molecular Cancer Research. 9(7). 925–935. 42 indexed citations
11.
Lv, Shengqing, Young Ho Kim, Giulio Fiaschetti, et al.. (2011). Genetic Alterations in MicroRNAs in Medulloblastomas. Brain Pathology. 22(2). 230–239. 46 indexed citations
12.
Castelletti, Deborah, Giulio Fiaschetti, Valeria Di Dato, et al.. (2010). The Quassinoid Derivative NBT-272 Targets Both the AKT and ERK Signaling Pathways in Embryonal Tumors. Molecular Cancer Therapeutics. 9(12). 3145–3157. 11 indexed citations
13.
Shalaby, Tarek, André O. von Bueren, Giulio Fiaschetti, et al.. (2010). Disabling c-Myc in Childhood Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor Cells by the Potent G-Quadruplex Interactive Agent S2T1-6OTD. Molecular Cancer Therapeutics. 9(1). 167–179. 39 indexed citations
14.
Bueren, André O. von, Tarek Shalaby, Davide Sciuscio, et al.. (2010). Expression of O6-methylguanine-DNA methyltransferase in childhood medulloblastoma. Journal of Neuro-Oncology. 103(1). 59–69. 10 indexed citations
15.
Bueren, André O. von, Tarek Shalaby, Christoph Oehler‐Jänne, et al.. (2009). RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells. BMC Cancer. 9(1). 10–10. 40 indexed citations
16.
Schramm, Alexander, Kathrin T. Doepfner, Tarek Shalaby, et al.. (2008). Targeting the Phosphoinositide 3-Kinase Isoform p110δ Impairs Growth and Survival in Neuroblastoma Cells. Clinical Cancer Research. 14(4). 1172–1181. 60 indexed citations
17.
Stücklin, Ana Guerreiro, Sarah Fattet, Barbara Fischer, et al.. (2008). Targeting the PI3K p110α Isoform Inhibits Medulloblastoma Proliferation, Chemoresistance, and Migration. Clinical Cancer Research. 14(21). 6761–6769. 67 indexed citations
18.
Bueren, André O. von, Tarek Shalaby, Duncan Stearns, et al.. (2007). Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells. BMC Cancer. 7(1). 19–19. 32 indexed citations
19.
Shalaby, Tarek, Doris Lang, André O. von Bueren, et al.. (2006). Quantitative mRNA expression analysis of neurotrophin‐receptor TrkC and oncogene c‐MYC from formalin‐fixed, paraffin‐embedded primitive neuroectodermal tumor samples. Neuropathology. 26(5). 393–399. 8 indexed citations
20.
Hemphill, Andrew, et al.. (2000). Nucleoside diphosphate kinase of Trypanosoma brucei. Gene. 257(2). 251–257. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshihiko Kuroda Breakdown of academic impact, for papers by Anna Onnis Breakdown of academic impact, for papers by Andrea Muscat Breakdown of academic impact, for papers by Wim Vos Breakdown of academic impact, for papers by Anna Coenen-Stass Breakdown of academic impact, for papers by Sarah J. Hill Breakdown of academic impact, for papers by Adam Studebaker Breakdown of academic impact, for papers by Rainer Will Breakdown of academic impact, for papers by Abeba Tesfaye Breakdown of academic impact, for papers by Anna Kalota
Rankless by CCL
2026